Internal Medicine, Gastroenterology · Downey, CA
NPI
1053377093
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
11480 Brookshire Avenue, Suite 308
Downey, CA, 90241
Phone (562) 862-3656
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
826 services
Medicare patients, 2024
402
Average age 73
Drug cost, 2024
$109K
933 prescriptions
Company payments, 2025
$441
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sushil K Ojha was code 99232 (hospital e&m - subsequent), 481 times for 233 patients. In total Sushil K Ojha billed 826 services in 24 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 481 | 233 | $61.67 | $30K |
| 99223 Hospital E&M - Initial | Facility | 115 | 112 | $135.41 | $16K |
| 43239 Upper GI Endoscopy | Facility | 51 | 50 | $86.43 | $4,408 |
| 99214 Office E&M - Established | Office | 43 | 34 | $95.28 | $4,097 |
| 99204 Office E&M - New | Office | 31 | 31 | $127.03 | $3,938 |
| 45378 Lower GI Endoscopy - Other | Facility | 24 | 24 | $116.94 | $2,807 |
| 43246 Upper GI Endoscopy | Facility | 19 | 19 | $154.83 | $2,942 |
By year: 2022 $58K for 616 services; 2023 $52K for 543 services; 2024 $73K for 826 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sushil K Ojha prescribed most often to Medicare patients was Pantoprazole Sodium, with 318 prescriptions and refills. In total Sushil K Ojha wrote 933 Medicare prescriptions that cost $109K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 318 | 582 | 120 | $2,603 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 153 | 153 | 145 | $21K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 105 | 105 | 103 | $1,408 |
| Sucralfate Generic | 56 | 64 | 20 | $1,390 |
| Omeprazole Generic | 43 | 67 | 17 | $261 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 25 | 25 | 23 | $339 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 21 | 21 | 21 | $1,090 |
| Dexlansoprazole Dr Dexlansoprazole | 20 | 30 | Under 11 | $4,975 |
| Famotidine Generic | 18 | 30 | Under 11 | $143 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 18 | 18 | 18 | $321 |
| Ibsrela Tenapanor Hcl | 16 | 16 | Under 11 | $26K |
| Cholestyramine Cholestyramine (With Sugar) | 13 | 17 | Under 11 | $630 |
Brand drugs: - claims; generic drugs: 703 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sushil K Ojha $441 ($441 in general payments such as food, travel and fees) from 7 companies. The largest payer was Ardelyx, Inc. with $201.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.